Embecta

NSQ:EMBC · US29082K1051

Health Care Equipment & SuppliesMedium

360

Value74

Profit price78

EV / EBIT94

Price / Owner Earnings61

Cash yield94

Owner Earnings Yield98

Dividend Yield89

Sales & asset price87

Price/Sales100

EV / Gross Profit82

Price/Book78

Quality80

Returns on capital100

Return on Capital100

Cash Return on Capital100

Profit margins92

EBIT Margin92

Gross Profitability92

Cash backing73

Cash Conversion48

Accruals81

Owner Earnings Margin90

Growth22

Sales growth19

Profit growth46

Profit Growth71

Long-Term EPS Growth1

Owner Earnings Growth65

Reinvestment89

Price momentum8

Safety23

Debt load5

Debt serviceability61

Refinancing100

Debt Payback21

Liquidity67

Sentiment56

Analyst ratings1

Expectations trend41

Opinion Changes14

Price Target Upside68

Market mood33

Value Creation14/20strong value creator

Creates more value than its capital costs
Owner earnings growing
Owner earnings per share growing
Reinvests at strong returns
Solid earnings base

What this means

Embecta generates returns well above its cost of capital, the foundation of durable shareholder value.

Profile

CountryUSA

IndustryHealth Care Equipment & Supplies

SizeMedium

TypePublic Company

ExchangeNASDAQGS

Founded2021

Employees866

Websiteembecta.com

ISINUS29082K1051

Last UpdateApr 2, 2026

Indices

NASDAQ (USA)

Themes

DiabetesBiomedical Engineering

Description

Embecta Corp. (Embecta) operates as a global medical device company. The company focuses on providing solutions to improve the health and well-being of people living with diabetes. The company has a broad portfolio of marketed products, including a…

Analysis

Hidden champion

Embecta Corp. is what we call a hidden champion: a strong business that the market is not pricing as one.

The price is attractive. You pay 1.2× its owner earnings: the cash an owner could take out each year, which is in the historically attractive zone. At today's price, the market is assuming roughly -40% yearly growth; analysts expect -10%. The price, in other words, assumes less than the experts do.

The trajectory is tepid and the balance sheet is stretched. The company scores 14/20 on our value-creation score: strong value creator.

What to watch: The financial cushion is thinner than comfortable. Some accounting patterns deserve a closer look. As always: this describes the company's numbers; it is not a recommendation.

360° rank · history

1007550250

2026

All-time high

Mar 2026

All-time low

Jun 2026

Average rank

across all years

Detailed & Historical Ranks

Deep dive into 15 detailed ranks and 3 years of history.

Current202520242023

Price/Sales

100

—

Price/Earnings

—

Price/Book

—

Dividend Yield

—

Value (overall)

100

—

Cells are coloured by rank band (red weak → green strong). Sentiment & 360° history begins 2023.

Similar Stocks

The companies this stock is ranked against.

Compare Embecta with its peers

Sharps Technology

NAQ:STSS

CountryUSA

IndustryHealth Care Equipment & Supplies

SizeX-Small

Full Stock Analysis →

Rezolute

NAQ:RZLT

CountryUSA

IndustryBiotechnology

SizeSmall

Full Stock Analysis →

Planet Image International

NAQ:YIBO

CountryUSA

IndustryCommercial Services & Supplies

SizeSmall

Full Stock Analysis →

Roadzen

NMQ:RDZN

CountryUSA

IndustrySoftware

SizeSmall

Full Stock Analysis →

iRhythm Technologies

NSQ:IRTC

CountryUSA

IndustryHealth Care Equipment & Supplies

SizeMedium

Full Stock Analysis →

MannKind

NMQ:MNKD

CountryUSA

IndustryBiotechnology

SizeMedium

Full Stock Analysis →

Make Sense of the Ranks

Every rank runs 1–100 against true peers. Higher is always better.

360° View

1 · Watch OutGood· 100

Value

1 · ExpensiveGood Value· 100

Quality

1 · Weak FundamentalsHigh Quality· 100

Growth

1 · Tough TimesHigh Growth· 100

Safety

1 · High LeverageWell-Financed· 100

Sentiment

1 · SkepticismPositive· 100

Learn More →